Does Right‐Hand Motor Impairment Affect Performance on Cognitive Testing in Parkinson's Disease?
ABSTRACT Background For People with Parkinson's (PwP), motor disturbances affecting the dominant upper extremity often impacts ability to perform tasks such as writing or typing and may confound cognitive test performances with graphomotor responding. Objectives We explored association between upper extremity impairment and graphomotor cognitive test ...
Priyanka Rao+2 more
wiley +1 more source
Editorial: Visuospatial and visuoconstructional abilities and disorders across the life span. [PDF]
Zappullo I+4 more
europepmc +1 more source
Adult‐Onset Dystonia‐Parkinsonism: Do Not Forget SERAC1
Movement Disorders Clinical Practice, EarlyView.
Giulia Scacciatella+15 more
wiley +1 more source
The role of neuropsychological assessment in the evaluation of patients with cognitive-behavioral change due to suspected Alzheimer's disease and other causes of cognitive impairment and dementia. [PDF]
Shaughnessy LW, Weintraub S.
europepmc +1 more source
Micrographia in Parkinson's Disease: Automatic Recognition through Artificial Intelligence
Abstract Background Parkinson's disease (PD) leads to handwriting abnormalities primarily characterized by micrographia. Whether micrographia manifests early in PD, worsens throughout the disease, and lastly responds to L‐Dopa is still under scientific debate.
Francesco Asci+8 more
wiley +1 more source
A Proposal for Neurocognitive Assessment in Spanish-Speaking Adults With Phelan-McDermid Syndrome: A Case Report. [PDF]
Flores Medina Y+4 more
europepmc +1 more source
Cognitive Changes in Pre‐ataxic Spinocerebellar Ataxias: A Scoping Review
Abstract Background Although traditionally recognized for motor impairment, evidence suggests that cognitive deficits may emerge before ataxia onset in autosomal dominant spinocerebellar ataxias (SCA), particularly in nucleotide repeat expansion SCAs (NRE‐SCAs).
Renata Barreto Tenorio+3 more
wiley +1 more source
Conceptualisation of financial capability in adults with acquired cognitive impairment: A qualitative evidence synthesis. [PDF]
Swan S+3 more
europepmc +1 more source
Abstract Background Individual variability in clinical response to dopamine replacement therapy (DRT) is a key barrier to efficacious treatment for patients with Parkinson's disease (PD). A better understanding of the neurobiological sources of such interindividual differences is necessary to personalize DRT prescribing, inform future clinical ...
Alex I. Wiesman+5 more
wiley +1 more source